Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies – MedCity News
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Credit: 123RF.com Biotechnology firm Pandorum Technologies has raised $18 million (Rs 163 crore) in a Series B round to advance…
Sports software, gene therapies, landlord pet rules: NC’s top startup deals of 2025 Durham Herald Sun Source link
Sports software, gene therapies, landlord pet rules: NC’s top startup deals of 2025 Durham Herald Sun Source link
The 2025 edition of the Boldbrain Startup Challenge, the acceleration programme for innovative ideas organised by Fondazione Agire with the…